These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 21255216)

  • 1. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
    Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
    Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
    J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats.
    Hata T; Mera Y; Kawai T; Ishii Y; Kuroki Y; Kakimoto K; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 Jul; 13(7):629-38. PubMed ID: 21362121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
    Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
    J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, reduces food preference for fat.
    Mera Y; Hata T; Ishii Y; Tomimoto D; Kawai T; Ohta T; Kakutani M
    J Diabetes Res; 2014; 2014():583752. PubMed ID: 24959597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 11beta-hydroxysteroid dehydrogenase inhibitor on body weight and glucose tolerance in Sprague-Dawley rats fed with a high-fat diet.
    Liu ZJ; Bai J; Wang YC; Yan D; Wang XX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):183-7. PubMed ID: 17582250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake of medium- and long-chain triacylglycerols ameliorates insulin resistance in rats fed a high-fat diet.
    Terada S; Yamamoto S; Sekine S; Aoyama T
    Nutrition; 2012 Jan; 28(1):92-7. PubMed ID: 21872431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
    Cani PD; Neyrinck AM; Maton N; Delzenne NM
    Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats.
    Nakajima S; Hira T; Hara H
    Br J Nutr; 2015 May; 113(9):1477-88. PubMed ID: 25827219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
    Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
    Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide promotes weight loss via suppression of intestinal MTP and apoB48 expression in diet-induced obesity rats.
    Huang W; Liu R; Ou Y; Li X; Qiang O; Yu T; Tang CW
    Nutrition; 2013 Oct; 29(10):1259-65. PubMed ID: 23911221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
    Sakata S; Ito M; Mera Y; Sasase T; Yamamoto H; Kakutani M; Ohta T
    J Diabetes Res; 2014; 2014():803832. PubMed ID: 24895641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats.
    Liu SZ; Sun D; Zhang GY; Wang L; Liu T; Sun Y; Li MX; Hu SY
    Chin Med J (Engl); 2012 Mar; 125(5):912-9. PubMed ID: 22490596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet.
    Yamamoto N; Kanemoto Y; Ueda M; Kawasaki K; Fukuda I; Ashida H
    Food Funct; 2011 Jan; 2(1):45-52. PubMed ID: 21773585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation of SK1 from Platycodi radix ameliorates obesity and glucose intolerance in mice fed a high-fat diet.
    Kim JY; Moon KD; Seo KI; Park KW; Choi MS; Do GM; Jeong YK; Cho YS; Lee MK
    J Med Food; 2009 Jun; 12(3):629-36. PubMed ID: 19627213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
    Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M
    Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.